B sample confirms Jumbo-Visma's Michel Hessmann took prohibited substance

German rider faces a ban from cycling and even criminal prosecution

Clock12:52, Friday 3rd November 2023
Michel Hessmann last rode for Jumbo-Visma at the Czech Tour, but was suspended by the team in August

© Velo Collection (TDW) / Getty Images

Michel Hessmann last rode for Jumbo-Visma at the Czech Tour, but was suspended by the team in August

At the request of German newspaper Badische Zeitung, the National German Anti-Doping Agency (NADA Germany) has confirmed that Jumbo-Visma rider Michel Hessmann's anti-doping violation has been upheld by analysis of his B sample.

The German rider tested positive for a diuretic medicine on June 14 in an out-of-competition test, and this A sample result has subsequently been supported by the B sample.

As written by the press officer for NADA Germany, Eva Bunthoff, the two samples show "sufficient evidence of a violation of anti-doping rules" and, in turn, Hessmann can now await a suspension from the UCI and potential public prosecution in Germany.

Since 2015, doping has been a criminal offence in Germany and, as a resident of Merzhausen, the 22-year-old is liable for charges from the Public Prosecution Service (OM).

Initial investigations into the athlete began in the summer following his positive doping test, with his residency searched and electronic items taken away to be analysed.

With his B sample result confirming that of the A sample, Hessmann will face charges of having administered a so-far unnamed diuretic medicine. Such prohibited substances carry a maximum suspension of up to four years by the UCI. For the time being, Hessmann remains suspended by Jumbo-Visma but as of yet, they have not commented on NADA Germany's revelation.

It must be noted that, although doping can carry up to a three-year prison sentence in Germany, no athlete has yet served time behind bars for such an offence. Instead, a fine is much more likely to be the punishment handed down to Hessmann.

For a team that won all three Grand Tours in 2023, the Hessmann affair is a blotch on Jumbo-Visma's season, with the German riding in service of the eventual Giro d'Italia champion, Primož Roglič, in May. This was to be Hessmann's last race before the positive doping test, though he would also race the Czech Tour and the UCI World Championships Road Race in August before the case emerged.

Hessmann has ridden for the Dutch superteam since 2020, with two years in the Development Team followed by three years in the WorldTour ranks.

Related Content

Link to Jumbo-Visma suspend Michel Hessmann after positive anti-doping test
Michel Hessmann in action at the Giro d'Italia earlier this year

Jumbo-Visma suspend Michel Hessmann after positive anti-doping test

German returned positive out-of-competition test in June after racing Giro d’Italia

Clock
Link to Toon Aerts found guilty of doping violation, banned for two years
Toon Aerts at the Superprestige race in Gavere in February 2022

Toon Aerts found guilty of doping violation, banned for two years

UCI decision states the Belgian ‘failed to establish how the prohibited substance entered his body’

Clock
Link to 'Giro d'Italia climbs play into my ballpark' says resurgent Ben O'Connor
Ben O'Connor's Giro d'Italia has turned around since he struggled to the top of Santuario di Oropa on stage 2

'Giro d'Italia climbs play into my ballpark' says resurgent Ben O'Connor

After previously describing himself as the ‘dumbest guy in the race,’ Decathlon AG2R La Mondiale’s Australian is on the up and gunning for podium

Clock
Link to Giro d’Italia stage 8 preview: Does Tadej Pogačar’s lead make a breakaway win inevitable?
Tadej Pogačar has a strong lead in the GC at the Giro d'Italia

Giro d’Italia stage 8 preview: Does Tadej Pogačar’s lead make a breakaway win inevitable?

The Slovenian might be in complete control but the top-ten battle still has plenty of life as riders head for the mountains

Clock
Subscribe to the GCN Newsletter

Get the latest, most entertaining and best informed news, reviews, challenges, insights, analysis, competitions and offers - straight to your inbox